Royce & Associates’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-26,851
| Closed | -$718K | – | 895 |
|
|
2023
Q3 | $718K | Sell |
26,851
-12,266
| -31% | -$328K | 0.01% | 775 |
|
|
2023
Q2 | $1.45M | Sell |
39,117
-6,432
| -14% | -$238K | 0.01% | 706 |
|
|
2023
Q1 | $1.42M | Buy |
45,549
+19,791
| +77% | +$618K | 0.01% | 723 |
|
|
2022
Q4 | $767K | Sell |
25,758
-27,772
| -52% | -$827K | 0.01% | 788 |
|
|
2022
Q3 | $2.04M | Sell |
53,530
-6,593
| -11% | -$251K | 0.02% | 624 |
|
|
2022
Q2 | $3.28M | Sell |
60,123
-4,884
| -8% | -$266K | 0.03% | 578 |
|
|
2022
Q1 | $4.06M | Buy |
65,007
+55,212
| +564% | +$3.45M | 0.03% | 599 |
|
|
2021
Q4 | $985K | Buy |
9,795
+4,878
| +99% | +$491K | 0.01% | 808 |
|
|
2021
Q3 | $442K | Buy |
+4,917
| New | +$442K | ﹤0.01% | 914 |
|
|
2020
Q1 | – | Sell |
-48,209
| Closed | -$622K | – | 1164 |
|
|
2019
Q4 | $622K | Hold |
48,209
| – | – | 0.01% | 863 |
|
|
2019
Q3 | $501K | Sell |
48,209
-3,464
| -7% | -$36K | ﹤0.01% | 901 |
|
|
2019
Q2 | $345K | Buy |
51,673
+14,612
| +39% | +$97.6K | ﹤0.01% | 943 |
|
|
2019
Q1 | $221K | Hold |
37,061
| – | – | ﹤0.01% | 994 |
|
|
2018
Q4 | $117K | Sell |
37,061
-35,350
| -49% | -$112K | ﹤0.01% | 997 |
|
|
2018
Q3 | $285K | Hold |
72,411
| – | – | ﹤0.01% | 999 |
|
|
2018
Q2 | $300K | Buy |
72,411
+4,500
| +7% | +$18.6K | ﹤0.01% | 1037 |
|
|
2018
Q1 | $270K | Buy |
67,911
+17,900
| +36% | +$71.2K | ﹤0.01% | 1077 |
|
|
2017
Q4 | $219K | Buy |
+50,011
| New | +$219K | ﹤0.01% | 1084 |
|